ErythroMycin Hydrolyzed Metabolite Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

A hydrolyzed metabolite of Erythromycin (E649950).

ErythroMycin Hydrolyzed Metabolite Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ErythroMycin Hydrolyzed Metabolite Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
Chemsky (shanghai) International Co.,Ltd	021-50135380	shchemsky@sina.com	China	15402	60
Shanghai TaoSu Biochemical Technology Co., Ltd.	021-33632979	info@tsbiochem.com	China	8065	58
BOC Sciences	16314854226	inquiry@bocsci.com	United States	9713	58
Energy Chemical	021-58432009 400-005-6266	marketing@energy-chemical.com	China	44918	58
Hubei Danding Pharmaceutical Technology Co., Ltd	18917019315 18917019315	18917019315@163.cn	China	9161	58

---

• ErythroMycin Hydrolyzed Metabolite
• seco ErythroMycin
• [2R-(2R*,3S*,4S*,5R*,6R*,8R*,10R*,11R*,12R*,13R*)]-3-[(2,6-Dideoxy-3-C-Methyl-3-O-Methyl-α-L-ribo-hexopyranosyl)oxy]-6,11,12,13-tetrahydroxy-2,4,6,8,10,12-hexaMethyl-9-oxo-5-[[3,4,6-trideoxy-3-(diMethylaMino)-β-D-xylo-hexopyranosyl]oxy]pentadecanoic Acid
• Reaxys ID: 5469935
• Pentadecanoic acid, 3-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-6,11,12,13-tetrahydroxy-2,4,6,8,10,12-hexamethyl-9-oxo-5-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [2R-(2R*,3S*,4S*,5R*,6R*,8R*,10R*,11R*,12R*,13R*)]- (9CI)
• 143416-84-6
• Amines
• Carbohydrates & Derivatives
• Heterocycles
• Intermediates & Fine Chemicals
• Pharmaceuticals
• Amines, Carbohydrates & Derivatives, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals